New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
09:09 EDTMNKDMannKind price target raised to $15 from $12 at Brinson Patrick
Brinson Patrick raised its price target for MannKind shares to $15 citing the FDA Approval of Afrezza for diabetes. The firm says the labeling, REMS program, and post-marketing requirements exceeded its expectations. It keeps an Outperform rating on the stock.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
16:05 EDTMNKDMannKind files automatic mixed securities shelf
Subscribe for More Information
August 31, 2015
05:36 EDTMNKDStocks with implied volatility movement; MNKD ABT
Subscribe for More Information
August 27, 2015
05:54 EDTMNKDStocks with implied volatility above IV index mean; MNKD AMBA
Subscribe for More Information
August 26, 2015
05:52 EDTMNKDStocks with implied volatility movement; TSM MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use